What is the recommended evaluation and management for a pelvic inclusion cyst?

Pelvic Inclusion Cyst: Evaluation and Management

Peritoneal inclusion cysts are benign lesions that require no intervention beyond gynecologic referral when diagnosed with characteristic ultrasound features, as they carry less than 1% risk of malignancy.

Diagnostic Evaluation

Ultrasound Characteristics (O-RADS 2 Classification)

The diagnosis of peritoneal inclusion cyst is made by transvaginal ultrasound demonstrating specific features 1:

• Follows the contour of adjacent pelvic organs or peritoneum without exerting mass effect
• Typically contains septations
• The ovary is either at the margin or suspended within the lesion (pathognomonic feature)
• Classified as O-RADS 2 (almost certainly benign, <1% malignancy risk)

Imaging Approach

• Transvaginal ultrasound combined with transabdominal ultrasound is the primary diagnostic modality 2
• Transabdominal imaging provides better visualization when lesions are large or extend beyond the transvaginal field of view
• MRI may be used for further characterization if ultrasound findings are atypical or incomplete 1

Management Algorithm

When Classic Features Are Present

Referral to gynecologist is the recommended management 1:

• No routine follow-up imaging is required when diagnosis is confident
• Surgical intervention is reserved for symptomatic cases
• The cyst itself does not require treatment unless causing symptoms

Treatment Options for Symptomatic Cases

Surgical excision is first-line treatment when intervention is needed 3, 4, 5:

• Laparoscopic or robotic-assisted cystectomy with excision of redundant peritoneum
• Complete excision minimizes recurrence risk (though recurrence rates approach 50% even with surgery) 4, 5
• Debulking surgery is preferred over aggressive cytoreductive approaches in most cases

Sclerotherapy is an alternative for select patients 6:

• Catheter drainage followed by instillation of sclerosant (povidone-iodine or ethanol)
• Technically feasible with 100% success rate in small series
• May be considered for patients who are poor surgical candidates
• Requires daily instillation until drainage <5mL

Key Clinical Pearls

Patient Demographics

• Predominantly affects premenopausal women with history of pelvic surgery or inflammation 3, 5
• Rare in males but should remain in differential diagnosis 3, 4

Common Pitfalls to Avoid

1. Do not confuse with ovarian cysts: The suspended ovary within or at the margin of the cyst is the distinguishing feature 1
2. Do not overtreate asymptomatic lesions: These are benign reactive lesions, not neoplasms
3. Do not misclassify as higher O-RADS category: When classic features are present, use the specific diagnosis rather than generic descriptors that may lead to inappropriate management 1

Differential Diagnosis Considerations

When ultrasound features are atypical, consider:

• Paraovarian cysts (simple cyst separate from ovary, moves independently)
• Hydrosalpinx (tubular structure with endosalpingeal folds)
• Multilocular ovarian cysts (ovary not suspended within lesion)
• Low-grade cystic mesothelioma (extremely rare) 7

Long-term Follow-up

Imaging surveillance is essential due to high recurrence rates after surgical treatment 5:

• Follow-up every 3 months initially after intervention 6
• Long-term imaging surveillance recommended given recurrence potential up to 50%